Literature DB >> 25290630

Amplification of the immune response by agonistic antibodies.

E A Clark1, J A Ledbetter1.   

Abstract

During the last seven years, more than 1000 munine monoclonal antibodies (mAb) have been made which react with human leucocyte differentiation antigens. International workshops have extensively evaluated these mAb; over 25 differentiation antigens have been identified and included in an international WHO-approved nomenclature(1-3), called clusters of differentiation (CD). These are identified by both serological and biochemical analyses. In this article Ed Clark and Jeff Ledbetter summarize a subset of these mAb specific for differentiation antigens that, as agonists, induce activation, growth, or differentiation of lymphocytes.
Copyright © 1986. Published by Elsevier B.V.

Entities:  

Year:  1986        PMID: 25290630     DOI: 10.1016/0167-5699(86)90008-3

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  3 in total

1.  A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice.

Authors:  B Hardy; R Kovjazin; A Raiter; N Ganor; A Novogrodsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

2.  Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein.

Authors:  B Hardy; M Galli; E Rivlin; L Goren; A Novogrodsky
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

Review 3.  Characteristics and clinical trial results of agonistic anti-CD40 antibodies in the treatment of malignancies.

Authors:  Da-Ke Li; Wen Wang
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.